UCB

BRUSSELS, Belgium, May 17, 2011 - The International Bureau for Epilepsy (IBE) and biopharmaceutical company UCB today announced the launch of the 2011 Excellence in Epilepsy Journalism Award.

BRUSSELS, May 10, 2011 - UCB announced today results from a post hoc analysis of the RAPID 1 study published in the Journal of Rheumatology.

BRUSSELS, Belgium, September 13, 2010 - The Excellence in Epilepsy Journalism Award, a joint initiative of the International Bureau for Epilepsy (IBE) and UCB, recognizes and rewards journalists from across the world who produce informed and compelling news and feature stories on epilepsy, as decided by an independent, international judging panel.

BRUSSELS, Belgium, March 19, 2010 - Patients with neurological diseases need more help with their associated sleep-wake disturbances that can often make their underlying illness worse, say leading sleep specialists attending a sleep meeting hosted by biopharmaceutical company, UCB, to mark World Sleep Day.

SLOUGH, England, March 19, 2010 - As a committed supporter of World Sleep Day, UCB has joined forces with the World Association of Sleep Medicine (WASM) to raise awareness of the importance of sleep for health, and to encourage those with sleep-affected conditions to pay as much attention to the amount and quality of their sleep as they do to their diet and exercise.